| LB17 compare to other probiotics |
| LB17 Frequently Asked Questions |
|
|
| 100% Pure Antarctic Krill Oil |
| Astaxanthin - powerful antioxidant |
|
|
| Bacteria antifungal effect |
| Probiotic boost baby's immune system |
| Probiotic for Nasal Congestion |
| Probiotic improve children's health and fight disease |
| New Therapies for Psoriasis |
| Ontario Govt funds research in Probiotics |
| Antibiotics may help stop stomach cancer |
| Asthma rates soaring worldwide: experts at 4th World Asthma Meeting in Bangkok, Thailand |
| Antioxidants appear to ward of Diabetes (Type-2) |
| Antibiotics may increase chances of Breast Cancer |
| Antiobiotics linked to allergies, studies find |
| Hospital confirms bacteria (Clostridium difficile) death |
| Inflammatory Bowel Disease - Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) |
| The First Steps to a Strong Immune System |
| Study shows secret to gas free beans |
| Probiotic reduce atopic eczema in infants |
|
|
|
Ontario (Canada) Government
investing more than C$1.7 million
to create centre dedicated to research into probiotics.
Ministry of Enterprise
Government of Ontario, Canada
MAY 2, 2002
The Ontario government is investing more than C$1.7 million to help create Canada's first centre dedicated to research into probiotics, Training, Colleges and Universities Minister Dianne Cunningham announced today on behalf of the Enterprise, Opportunity and Innovation Ministry Jim Flaherty
Located at the Lawson Health Research Institute at St. Joshpeh's Health Care in London, the new Canadian Research and Development Centre for Probioitcs will lead cutting-edge research into probiotics, which is replenishment of "good bacteria" to counteract diesease in human and animals. Probiotics researchers at the Centre will work in partnership with researchers at the University of Guelph and the Ottawa Hospital Research Institute.
"Probiotics has enormous promise to improve the quality of health for people both here in Ontario and around the world," says Cunningham. "This new Centre will also create jobs and strengthen Ontario's economy by giving the province a leading role in developing and exporting related therapeutic technologies."
The multi-disciplinary research at the Centre will explore ways to harness the body's probiotic organisms and proteins to counteract a variety of urinary and digestive diseases and infections. The research will also study
the use of probiotics and prebiotics (substances that promote the growth of good bacteria) as an alternative to antibiotics in the treatment of livestock for human consumption.
The provincial investment is being made through the Ontario Research Development Callenge Fund and will leverage C$4.2 million in additional financial support from both the private sector and research institute partners.
The above information is provided for general
educational purposes only. It is not intended to replace competent
health care advice received from a knowledgeable healthcare professional.
You are urged to seek healthcare advice for the treatment of any
illness or disease.
Health Canada and the FDA (USA) have not evaluated these
statements. This product is not intended to diagnose, treat, cure, or prevent
any disease.
|
|
60 capsules per box
CAD$50.00
View
LB17 Testimonials
from users
|
